Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 780 participants.

Also called NCT07762560

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 780 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07762560
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07762560. Randomized; no masking; primary purpose treatment. Start 2027-05-01 (anticipated); primary completion 2030-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock
Acronym
DOUBLE-SHOCK
Condition
Cardiogenic Shock
Condition
Acute Myocardial Infarction (AMI)
Condition
Heart Failure, Acute
Intervention (Device)
Microaxial flow pump (left ventricular assist device)
Intervention (Device)
Pulmonary artery catheter
Intervention (Procedure)
Conventional hemodynamic monitoring
Intervention (Procedure)
Hemodynamic stabilization
Lead sponsor
Leipzig Heart Science gGmbH (class: other)
Collaborator
University of Southern Denmark (class: other)
Collaborator
Boston Scientific Corporation (class: industry)
Collaborator
Heart Center Leipzig - University Hospital (class: other)
Collaborator
Stiftung Institut fuer Herzinfarktforschung (class: other)

Record details

Record id
cardio:ct-nct07762560
Content hash
ded3ee3041435a8d490cba38c7c9968644e12b575d7195acc7717e974892e89a